[Effectiveness of bioparox treatment in acute inflammatory diseases of the upper airways].
Acute inflammation of the upper respiratory tract was treated with bioparox in 40 patients and conventionally in 20 patients. The assessment of the treatment effect was carried out by subjective and objective responses, rhinomanometry, trends in cell composition and phagocytic activity of leukocytes in smears from nasal mucosa. The data obtained provided evidence for high efficacy of bioparox which promoted faster regress of subjective and objective manifestations of the inflammation.